Sponsor Pipeline

Vanda Pharmaceuticals Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
20
Active Trials
13
Recruiting
12
Phase 3
8
Disease Areas
4
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-28 NCT04652882
Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder…
Enrollment closed, study ongoing
2026-07-28 NCT04652882
Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder…
date change Primary completion pushed: 2026-06 -> 2026-09
2026-07-28 NCT04652882
Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder…
date change Completion pushed: 2026-06 -> 2026-09
2026-07-21 NCT07221578
Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of…
overall status: Recruiting → Active, Not Recruiting
Active Trials by Phase
Phase 4
1
Phase 3
12
Phase 2
3
Phase 1/2
1
Phase 1
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT05648591 Safety and Tolerability of Open-Labeled Iloperidone in Adolescents Schizophrenia Recruiting
Phase 3
NCT06701396 Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder… Sleep Wake Disorders Recruiting
NCT06836557 Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis Idiopathic Gastroparesis Recruiting
NCT06961968 Randomized Withdrawal Study in Patients With Schizophrenia Schizophrenia Recruiting
NCT06830044 Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With… Major Depressive Disorder (MDD) Recruiting
NCT07446439 A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist… Nausea and Vomiting Recruiting
NCT06953869 Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia Insomnia Disorder Recruiting
NCT07362017 Open Label Study to Investigate the Safety and Efficacy of Ponesimod in… Moderate-to-severe Chronic Plaque Psoriasis Recruiting
NCT04326426 ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or… Coronavirus Infection Enrolling by Invitation
NCT06138613 Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected… Motion Sickness Active, Not Recruiting
NCT07686081 Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With… Ulcerative Colitis (UC) Not Yet Recruiting
NCT07221578 Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of… Social Anxiety Disorder (SAD) Active, Not Recruiting
NCT04652882 Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder… Sleep Wake Disorders Active, Not Recruiting
Phase 2
NCT07179055 An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in… Dry Eye Recruiting
NCT07090161 Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With… Hypertension Recruiting
NCT07065773 Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe… Onychomycosis of Toenail Active, Not Recruiting
Phase 1/2
NCT07223632 Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient Charcot Marie Tooth Disease (CMT) Active, Not Recruiting
Phase 1
NCT03838926 Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic… Relapsed or Refractory Hematologic Malignancies Recruiting
Not specified
NCT01195558 Patient Registry of Blind Subjects With Sleep-related Problems Sleep-wake Disorder in Blind Individuals Recruiting
NCT03154697 Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep… Sleep Disturbances in Smith-Magenis Syndrome Recruiting
Disease Areas
Get alerts when Vanda Pharmaceuticals's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free